Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06224166 | Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence | unknown | — | 283 | Regina Elena Cancer InstituteOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT06227039 | Patient Augmented Reality and Vibratory Array Otorhinolaryngology Procedures(PARVA) | unknown | N/A | 80 | University of VirginiaOTHER | 1 | Jan 26, 2024 |
| clinicaltrials |
| NCT03532737 | Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer | unknown | Phase 2 | 50 | Kuwait Cancer Control CenterOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03146650 | Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer | unknown | Phase 2 | 25 | Northwestern UniversityOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03708822 | Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 48 | Sun Yat-sen UniversityOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT04398524 | A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC | unknown | Phase 2 | 65 | ISA PharmaceuticalsINDUSTRY | 9 | Jan 16, 2024 | clinicaltrials |
| NCT06201039 | Continuous Local-anesthetic Wound Infusion for Neck Dissection(CLAWED) | unknown | N/A | 80 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Jan 11, 2024 | clinicaltrials |
| NCT06199947 | Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma | unknown | N/A | 119 | Poitiers University HospitalOTHER | 0 | Jan 10, 2024 | clinicaltrials |
| NCT04851925 | MR Fingerprinting for Vestibular Schwannomas | unknown | — | 50 | Medical University of ViennaOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT06032767 | Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep Learning | unknown | — | 480 | Sun Yat-sen UniversityOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT06101043 | PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy | unknown | N/A | 76 | Min Suk ChaeOTHER | 0 | Jan 5, 2024 | clinicaltrials |
| NCT03669718 | A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC | unknown | Phase 2 | 194 | ISA PharmaceuticalsINDUSTRY | 13 | Dec 29, 2023 | clinicaltrials |
| NCT06170697 | Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 46 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06178237 | RADA16 for Reducing Drain Output Trajectory Following Neck Dissection(ROUND) | unknown | N/A | 208 | St. James's Hospital, IrelandOTHER | 0 | Dec 20, 2023 | clinicaltrials |
| NCT00415233 | High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer(HiLo) | unknown | Phase 3 | 438 | University College, LondonOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT06170203 | Evaluation of the Implementation of Personalised Follow-up in Head and Neck Cancer(EMPOWER) | unknown | — | 33 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT04431648 | Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Head and Neck Cancer(USmBRT-H) | unknown | Phase 1 | 20 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06156878 | PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy | unknown | Phase 2 | 41 | Fudan UniversityOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06156891 | PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT06146985 | Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer | unknown | Phase 2 | 67 | Ruijin HospitalOTHER | 0 | Nov 28, 2023 | clinicaltrials |
| NCT05576272 | A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 460 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06107114 | Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma(CZCNRHNSCC) | unknown | Phase 2 | 52 | Xuekui LiuOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06142318 | Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 66 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT05989555 | Effects of Radioactive Iodine on the Immune System in Thyroid Cancer(SCIMITAR) | unknown | — | 30 | Radboud University Medical CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06103617 | Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer | unknown | Phase 2 | 10 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06136962 | Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life | unknown | — | 500 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06138483 | A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse | unknown | — | 267 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02624128 | Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck(V-CHANCE) | unknown | Phase 2 | 39 | National Cancer Institute, NaplesOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06121102 | Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain | unknown | N/A | 60 | National Cancer Institute, EgyptOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06129201 | Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging | unknown | — | 5,000 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT02229656 | Olaparib and Radiotherapy in Head and Neck Cancer | unknown | Phase 1 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05094804 | A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents | unknown | Phase 1 / Phase 2 | 172 | OncoResponse, Inc.INDUSTRY | 1 | Nov 2, 2023 | clinicaltrials |
| NCT05182931 | A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)(I-FIRST) | unknown | Phase 2 | 80 | Olivia Newton-John Cancer Research InstituteOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT03918382 | Patient-Reported Outcomes in Head and Neck Cancer(DAHANCA PRO) | unknown | N/A | 291 | Rigshospitalet, DenmarkOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT06011291 | A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer | unknown | Phase 1 | 73 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Oct 27, 2023 | clinicaltrials |
| NCT06102447 | Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma | unknown | N/A | 36 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT05817617 | Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis | unknown | — | 953 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT06100081 | Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck(REFLECT) | unknown | N/A | 35 | University Medical Center GroningenOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT04277858 | Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.(NECTORS) | unknown | Phase 2 | 60 | Nader SadeghiOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT04801953 | Nimodipine in Vestibular Schwanommas | unknown | Phase 2 | 30 | Medical University of ViennaOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT06090214 | Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE)(BLADE) | unknown | N/A | 42 | University Hospital, MontpellierOTHER | 0 | Oct 19, 2023 | clinicaltrials |
| NCT05545852 | A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC | unknown | N/A | 290 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05202626 | Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images | unknown | — | 100 | Chinese Academy of SciencesOTHER_GOV | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05259319 | Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)(IMMUNOs-SBRT) | unknown | Phase 1 | 92 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06086119 | Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers | unknown | — | 31 | Regina Elena Cancer InstituteOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06081582 | Toripalimab in Combined With Cetuximab,Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC | unknown | Phase 2 | 33 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT05217212 | Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer? | unknown | — | 100 | Luzerner KantonsspitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05626829 | Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma | unknown | Phase 2 | 18 | Jian GuanOTHER | 1 | Oct 6, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Jan 26, 2024source: clinicaltrials